• Home  /
  • Research & Analysis   /
  • 2 Hot Wallstreet Cakes: Nektar Therapeutics (NASDAQ:NKTR), Ares Capital Corporation (NASDAQ:ARCC)

2 Hot Wallstreet Cakes: Nektar Therapeutics (NASDAQ:NKTR), Ares Capital Corporation (NASDAQ:ARCC)

Nektar Therapeutics (NASDAQ:NKTR)

The shares of Nektar Therapeutics (NASDAQ:NKTR) started off the last trading session with the price of $103.08 while closing the day with the price of $105.01. The shares of Nektar Therapeutics (NASDAQ:NKTR) Rise 1.95% with the Gain of 1.93 points.

The shares of Nektar Therapeutics (NASDAQ:NKTR) traded with the day volume of 3.18 Million shares whereas its average trading volume is 3.1 Million.

While analyzing the past performance of the stock we can see that the shares of Nektar Therapeutics (NASDAQ:NKTR) Gain 1.88% in the last week while rising 27.84% in the last month. Past quarter performance shows the green light with 90.75%. The semi-annual and annual performance shows 376.24% and 577.48% respectively.

Some critical values of the shares of Nektar Therapeutics (NASDAQ:NKTR) to be discussed here are: the beta which shows the value at 1.91 while Average True Range of Nektar Therapeutics (NASDAQ:NKTR) demonstrate the value at 5.93. The weekly and monthly volatility of the shares of Nektar Therapeutics (NASDAQ:NKTR) are indicated at 4.97% and 5.70%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 65.15.

While studying the financial position of the shares of Nektar Therapeutics (NASDAQ:NKTR), we can see that the Market capitalization of the company is at 16.74 Billion. The shares outstanding for the company is 159.38 Million and the shares float stands at 159.38 Million. The income of the company stand at -96700000 while the sales stand at 307.7 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.64, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 54.39, the Return on Asset ROA stood at -0.185 and the Return on Equity ROE depicted at -1.757 while Return on Investment ROI is at -0.181.


Ares Capital Corporation (NASDAQ:ARCC)

Ares Capital Corporation (NASDAQ:ARCC) started its previous trading session at $15.38 and closed at $15.32 showing a Fell of -0.13 Percent.

The Company traded with an average Volume of 2.14 Million whereas, its Day Volume stood at 3.16 Million.

Looking at the performance of the stock, Ares Capital Corporation (NASDAQ:ARCC) Loss -3.89% in the last week in its shares price and -3.65% in the last month. Quarterly performance shows a red of -3.83 Percent while Semi-Annual and Annual performances shows a -2.67 and -11.09 percent respectively.

Beta for Ares Capital Corporation (NASDAQ:ARCC) stands at 0.67 while the ATR (average true range) is at 0.23. The Stock’s Weekly and Monthly Volatility is 1.35% and 1.17% respectively showing a RSI value of 35.25.

While studying the financial position of the shares of Ares Capital Corporation (NASDAQ:ARCC), we can see that the Market capitalization of the company is at 6.53 Billion. The shares outstanding for the company is 426.02 Million and the shares float stands at 424.44 Million.

The Company generated an income of 667 Million and the sales of 1.16 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $1.57 a share. P/E (price to earnings) and P/S (price to sales) values are 9.76 and 5.63 respectively.

The Return on Assets stands at 0.055, ROE shows a value of 0.095 and ROI for Ares Capital Corporation (NASDAQ:ARCC) is 0.042 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment